Active Ingredient History
Tea is an aromatic beverage prepared by pouring hot or boiling water over cured or fresh leaves of Camellia sinensis, an evergreen shrub native to East Asia which probably originated in the borderlands of southwestern China and northern Myanmar. Tea is also made, but rarely, from the leaves of Camellia taliensis. After plain water, tea is the most widely consumed drink in the world. There are many different types of tea; some have a cooling, slightly bitter, and astringent flavour, while others have profiles that include sweet, nutty, floral, or grassy notes. Tea has a stimulating effect in humans, primarily due to its caffeine content. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma (Phase 2)
Barrett Esophagus (Phase 1)
Blepharitis (Phase 4)
Breast Neoplasms (Phase 2)
Carcinoma, Basal Cell (Phase 2/Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Verrucous (Phase 4)
Cataract (Phase 2/Phase 3)
Colitis, Ulcerative (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Condylomata Acuminata (Phase 4)
COVID-19 (Phase 2)
Diabetes Mellitus (Phase 2/Phase 3)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Doping in Sports (Phase 1)
Dyslipidemias (Phase 3)
Epidermolysis Bullosa Dystrophica (Phase 2)
Esophageal Neoplasms (Phase 3)
Fear (Phase 2/Phase 3)
Fibrosis (Phase 1)
Gingivitis (Phase 3)
Halitosis (Phase 1/Phase 2)
Healthy Volunteers (Phase 2)
HIV Infections (Phase 1)
Hyperlipidemias (Phase 3)
Ichthyosis, Lamellar (Phase 3)
Infections (Phase 2/Phase 3)
Inflammation (Phase 3)
Influenza, Human (Phase 3)
Irritable Bowel Syndrome (Phase 2)
Kidney Failure, Chronic (Phase 2)
Leiomyoma (Phase 3)
Leukemia (Phase 1/Phase 2)
Lichen Planus, Oral (Early Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma, Follicular (Phase 2)
Melanoma (Phase 2)
Metabolic Diseases (Phase 4)
Multiple Myeloma (Phase 2)
Multiple Sclerosis (Phase 2)
Neoplasms (Phase 1)
Obesity (Phase 3)
Osteoporosis (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 3)
Papillomavirus Infections (Phase 2)
Pediculus (Phase 4)
Precancerous Conditions (Phase 2)
Prostatic Hyperplasia (Phase 2)
Prostatic Neoplasms (Phase 3)
Respiratory Tract Infections (Phase 2)
SARS-CoV-2 (Phase 3)
Stomach Neoplasms (Phase 3)
Stomatitis (Phase 2)
Tobacco Use Disorder (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vaginitis (Phase 4)
Warts (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
